SEVERAL HYDROPHOBIC AMINO-ACIDS IN THE P53 AMINO-TERMINAL DOMAIN ARE REQUIRED FOR TRANSCRIPTIONAL ACTIVATION, BINDING TO MDM-2 AND THE ADENOVIRUS-5 E1B 55-KD PROTEIN

被引:584
作者
LIN, JY [1 ]
CHEN, JD [1 ]
ELENBAAS, B [1 ]
LEVINE, AJ [1 ]
机构
[1] PRINCETON UNIV,DEPT MOLEC BIOL,PRINCETON,NJ 08544
关键词
P53; PROTEIN; TRANSACTIVATION; MDM-2; BINDING; E1B 55-KD BINDING;
D O I
10.1101/gad.8.10.1235
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The p53 tumor suppressor gene product is a transcriptional activator that may be associated with its ability to suppress tumor cell growth. The acidic amino terminus of the p53 protein has been shown to contain this trans-activation activity as well as the domains for mdm-2 and adenovirus 5 E1B 55-kD protein binding. An extensive genetic analysis of this amino terminal p53 domain has been undertaken using site-specific mutagenesis. The results demonstrate that the acidic residues in the amino terminus of p53 may contribute to, but are not critical for, this trans-activation activity. Rather, the hydrophobic amino acid residues Leu-22 and Trp-23 of human p53 are both required for trans-activation activity, binding to the adenovirus E1B 55-kD protein and the human mdm-2-p53 protein in vitro. In addition, hydrophobic residues Leu-14 and Phe-19 are crucial for the interactions between p53 and human mdm-2 (hdm-2). Hydrophobic residues Trp-23 and Pro-27 are also important for binding to the adenovirus 5 (Ad5) E1B 55-kD protein in vitro. These mutations have no impact on the ability of the p53 protein to bind to a p53-specific DNA element. These results suggest that 2-4 critical hydrophobic residues in the amino-terminal domain of the p53 protein interact with the transcriptional machinery of the cell resulting in transcriptional activation. These very same hydrophobic residues contact the hdm-2 and Ad5 E1B 55-kD oncogene products.
引用
收藏
页码:1235 / 1246
页数:12
相关论文
共 50 条
[31]  
OLSON DC, 1993, ONCOGENE, V8, P2353
[32]  
OROURKE RW, 1990, ONCOGENE, V5, P1829
[33]   THE DNA-BINDING DOMAIN OF P53 CONTAINS THE 4 CONSERVED REGIONS AND THE MAJOR MUTATION HOT-SPOTS [J].
PAVLETICH, NP ;
CHAMBERS, KA ;
PABO, CO .
GENES & DEVELOPMENT, 1993, 7 (12B) :2556-2564
[34]  
RAGIMOV N, 1993, ONCOGENE, V8, P1183
[35]   ANALYSIS OF P53 MUTANTS FOR TRANSCRIPTIONAL ACTIVITY [J].
RAYCROFT, L ;
SCHMIDT, JR ;
YOAS, K ;
HAO, MM ;
LOZANO, G .
MOLECULAR AND CELLULAR BIOLOGY, 1991, 11 (12) :6067-6074
[36]   TRANSCRIPTIONAL ACTIVATION BY WILD-TYPE BUT NOT TRANSFORMING MUTANTS OF THE P53 ANTIONCOGENE [J].
RAYCROFT, L ;
WU, H ;
LOZANO, G .
SCIENCE, 1990, 249 (4972) :1049-1051
[37]   DNA SEQUENCING WITH CHAIN-TERMINATING INHIBITORS [J].
SANGER, F ;
NICKLEN, S ;
COULSON, AR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1977, 74 (12) :5463-5467
[38]   ADENOVIRUS E1B-58KD TUMOR-ANTIGEN AND SV40 LARGE TUMOR-ANTIGEN ARE PHYSICALLY ASSOCIATED WITH THE SAME 54 KD CELLULAR PROTEIN IN TRANSFORMED-CELLS [J].
SARNOW, P ;
HO, YS ;
WILLIAMS, J ;
LEVINE, AJ .
CELL, 1982, 28 (02) :387-394
[39]   WILD-TYPE P53 BINDS TO THE TATA-BINDING PROTEIN AND REPRESSES TRANSCRIPTION [J].
SETO, E ;
USHEVA, A ;
ZAMBETTI, GP ;
MOMAND, J ;
HORIKOSHI, N ;
WEINMANN, R ;
LEVINE, AJ ;
SHENK, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (24) :12028-12032
[40]   INDUCTION OF APOPTOSIS BY WILD-TYPE P53 IN A HUMAN COLON TUMOR-DERIVED CELL-LINE [J].
SHAW, P ;
BOVEY, R ;
TARDY, S ;
SAHLI, R ;
SORDAT, B ;
COSTA, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (10) :4495-4499